CIENCIASMEDICASNEWS: Health News and Information - News Medical :: Cardiology

martes, 13 de marzo de 2018

Health News and Information - News Medical :: Cardiology - Mar 13, 2018 Edition

Health News and Information - News Medical

	March 13, 2018
	Cardiology
	The latest cardiology news from News Medical

SCHILLER’s FRED easyport defibrillator helps young triathlete to survive after cardiac arrest

SCHILLER Australia CEO Harry Packer has met 27 year old Fisher resident, Callan Fox, where he had the cardiac arrest, to hear his story and present him with a Swiss watch.

			New marker involved in lymphatic system linked to increased risk of heart failure Researchers at Lund University in Sweden have found a new marker in the blood that is associated with an increased risk of heart failure.

			Research finds correlation between perioperative air travel and high risk of venous thromboembolism New research presented at the 2018 Annual Meeting of the American Academy of Orthopaedic Surgeons found a correlation between flying following hip or knee arthroplasty and an increased risk of venous thromboembolism.

	Scientists discover 36 previously unknown genes implicated in heart failure One in four deaths in the United States each year are due to heart disease, according to the Centers for Disease Control and Prevention. It's the leading killer of both men and women, but the disease's genetic complexity makes it difficult to treat.

	Lower levels of protective molecules could increase heart attack risk in the morning Cardiovascular disease patients have lower levels of an important family of protective molecules in their blood in the morning, which could be increasing their risk of blood clots and heart attacks at those times, according to early research led by Queen Mary University of London.

	Vitamin D may help reduce risk of heart failure after heart attack New research has shown how vitamin D may help protect heart tissue and prevent heart failure after a heart attack, potentially offering a low-cost addition to existing treatments for heart failure.

	Stroke patients and their families need more emotional support, study suggests Doctors caring for severe stroke patients need to take account of their psychological needs and help prepare families for the possibility that they may not recover, a study suggests.

	Four-step heart attack protocol can improve outcomes and reduce gender disparities in care Cleveland Clinic researchers found that implementing a four-step protocol for the most severe type of heart attack not only improved outcomes and reduced mortality in both men and women, but eliminated or reduced the gender disparities in care and outcomes typically seen in this type of event.

	Novel centrifugal-flow pump for heart failure patients provides improved long-term outcomes New findings, presented today at the American College of Cardiology, provide long-term information about survival, stroke rates and durability of a novel centrifugal-flow pump compared with a commercial axial flow pump for heart-failure patients.

	Patients given six-month dual antiplatelet therapy have increased heart attack risk The combined rate of death from any cause, heart attack or stroke within 18 months was not significantly different in patients with acute coronary syndrome who were randomly assigned to receive dual antiplatelet therapy for either six months or at least 12 months after receiving a drug-eluting stent.

	Study identifies genetic defect linked to heart failure in African Americans Heart failure is more common, develops earlier and results in higher rates of illness and death in African Americans than in whites.

	Blood-thinning drug mitigates risk of complications, death after non-cardiac surgery Researchers in Hamilton have discovered that a blood-thinning drug, dabigatran, significantly reduces the risk of death, heart attack, stroke, and other heart or blood-vessel complications in patients who have a heart injury following major, non-cardiac surgery.

	Inhaled therapy for heart failure fails to meet either primary or secondary endpoints Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily activity levels, severity of symptoms or quality of life in patients with a type of heart failure for which no effective treatment options currently exist, according to research presented at the American College of Cardiology's 67th Annual Scientific Session.

	What is Valvular Heart Disease? This article describes the structure of the heart, position and role of the heart valves, and how damage can lead to valvular heart disease.

	New version of troponin test can detect heart attack within one hour When Marc Hammer went to the emergency room feeling fatigued and dizzy, he had no idea his life was actually at risk. "I'm an avid cyclist and walk five to 15 miles a day," said Hammer, "so you can imagine my shock when I found out I was facing a heart issue. It came out of the blue."

	Protein pathways linked to heart disease, diabetic complications identified in patients with diabetes Protein pathways that are closely linked to changes in both triglyceride and hemoglobin A1c levels in diabetic patients have been identified in new research by the Intermountain Medical Center Heart Institute in Salt Lake City.

	Research finds decrease in device malfunction, reduced risk for strokes with novel heart pump At two years of follow-up, severely ill patients with advanced heart failure who received a novel heart pump fully implantable within the chest experienced no malfunctions requiring replacement or removal of the device for blood clotting.

	Wearable defibrillator reduces overall mortality, but not sudden cardiac death Wearing a lightweight vest equipped with a cardioverter defibrillator that detects abnormal heart rhythms in addition to taking recommended medications is associated with a reduction in the likelihood of dying during the first 90 days following a heart attack in people whose heart function was also impaired, according to a study presented at the American College of Cardiology's 67th Annual Scientific Session.

	PCSK9 inhibitor reduces cardiovascular events in ACS patients with high cholesterol Among patients with persistently high cholesterol despite high-intensity statin therapy, the proprotein convertase subtilisin-kexin 9 (PCSK9) inhibitor alirocumab reduced rates of major adverse cardiovascular events by 15 percent compared with placebo, in a study presented at the American College of Cardiology's 67th Annual Scientific Session.